Kalsbeek A, van Heerikhuize J J, Wortel J, Buijs R M
Netherlands Institute for Brain Research, Amsterdam, The Netherlands.
J Neurosci. 1996 Sep 1;16(17):5555-65. doi: 10.1523/JNEUROSCI.16-17-05555.1996.
The mammalian suprachiasmatic nuclei (SCN) contain an endogenous pacemaker that generates daily rhythms in behavior and secretion of hormones. We hypothesized that the SCN imposes its circadian rhythm on the rest of the brain via a rhythmic release of its transmitters in its target areas. Previously, we demonstrated a pronounced inhibitory effect of vasopressin (VP), released from SCN terminals in the dorsomedial hypothalamus, on the release of the adrenal hormone corticosterone. In the present study, microdialysis-mediated intracerebral administration of the VP V1-receptor antagonist was used to pursue the study of the mechanisms underlying the circadian control of basal corticosterone release. Using timed administrations of the VP antagonist divided equally over the day/night cycle, we were able to uncover the existence of an additional stimulatory input from the SCN to the hypothalamopituitary-adrenal (HPA) axis. Peak activity of this stimulatory SCN input takes place during the second half of the light period, after the daily peak of VP secretion, with a delay of approximately 4-6 hr. In all likelihood, the inhibitory and stimulatory circadian input via separate mechanisms affects corticosterone release. Together, these two opposing circadian control mechanisms of the HPA axis enable a precise timing of the circadian peak in corticosterone release.
哺乳动物的视交叉上核(SCN)含有一个内源性起搏器,可产生行为和激素分泌的每日节律。我们假设SCN通过在其靶区域有节律地释放其递质,将其昼夜节律强加于大脑的其他部分。此前,我们证明了从下丘脑背内侧的SCN终末释放的血管加压素(VP)对肾上腺激素皮质酮的释放有明显的抑制作用。在本研究中,使用微透析介导的VP V1受体拮抗剂脑内给药来研究基础皮质酮释放昼夜控制的潜在机制。通过在昼夜周期中平均分配VP拮抗剂的定时给药,我们能够发现SCN对下丘脑-垂体-肾上腺(HPA)轴存在额外的刺激性输入。这种刺激性SCN输入的峰值活动发生在光照期的后半段,在VP分泌的每日峰值之后,延迟约4-6小时。很可能,通过不同机制的抑制性和刺激性昼夜输入会影响皮质酮的释放。这两种相反的HPA轴昼夜控制机制共同作用,使皮质酮释放的昼夜峰值能够精确计时。